Status not kept up to date
Robotic Exoskeleton With Functional Electrical Stimulation in Acute Spinal Cord Injury
NCT04250688 · Shirley Ryan AbilityLab · Updated 7 March 2023
- What is being tested
- Ekso Training with FES
- For
- Spinal Cord Injuries
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 70 years. About 10 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Jan 2016, ends 31 Dec 2023. Registered 31 Jan 2020.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to examine the effectiveness of mobility training using the Ekso robotic exoskeleton with functional electrical stimulation (FES) in persons affected by spinal cord injury; designated AIS classification A, B, C, or D. Traditionally, a person with an American Spinal Injury Association Impairment Scale (AIS) "A" injury, walking training is not performed. Even with AIS B, C and D injuries, although walking training may be appropriate, a person may not walk as much as needed to see an improvement due to environmental and staff limitations. The Ekso is a tool to give walking training to patients. The investigators aim to see if utilizing these technologies will affect recovery; specifically in sensation and muscle activity below the level of the injury as well as the ability to walk. The Ekso is a wearable, battery- operated exoskeleton that assists with walking. The Ekso has motors at the hip and knee joints to provide assistance that may be needed with walking. All motion is initiated either through body weight shifts or the use of an external controller. The Ekso robotic exoskeleton has been approved by the Food and Drug Administration as a powered exercise device for rehabilitative purposes such as this study. Currently, the Ekso is approved for people with spinal cord injuries from T4-L5 given bilateral arm strength of 4/5. With injuries from…
